I've looked for patents related to HCV treatment and the French scientist from whom BLRX got BL-8020 and BL-8030 and perhaps the idea is to coformulate the PI with hydroxychloroqune. See:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.